SLShanelle De Lancy

Shanelle De Lancy

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shanelle De Lancy has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Amanda M. Ackermann

    Division of Endocrinology and Diabetes, The Children’s Hospital of Philadelphia, Philadelphia, PA

    1 shared publication
  • Boaz Karmazyn

    Department of Radiology and Imaging Sciences Indiana University School of Medicine, Riley Hospital for Children at IU Health Indianapolis Indiana USA

    1 shared publication
  • Demitrios Dedousis

    Department of Genetics and Genome Sciences and Center for Human Genetics, University Hospitals Cleveland Medical Center/Rainbow Babies and Children’s Hospital, Case Western University School of Medicine, Cleveland, OH, USA

    1 shared publication
  • Denise D Young

    Division of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University Hospitals Cleveland Medical Center/Rainbow Babies and Children’s Hospital, Case Western University School of Medicine, Cleveland, OH, USA

    1 shared publication
  • Diane W. Chen

    Department of Otolaryngology–Head and Neck Surgery Indiana University School of Medicine Indianapolis Indiana USA

    1 shared publication
  • Edwin C Ferren

    Department of Genetics and Genome Sciences and Center for Human Genetics, University Hospitals Cleveland Medical Center/Rainbow Babies and Children’s Hospital, Case Western University School of Medicine, Cleveland, OH, USA

    1 shared publication

Latest Publications

  • Open Access

    Contrast‐Enhanced Ultrasound in the Diagnosis of Parotid Gland Castleman Disease in a Child

    by Sruthilatha Sakthi Velavan, Shanelle De Lancy, Diane W. Chen, Boaz Karmazyn

    Castleman disease is a rare lymphoproliferative disorder that infrequently involves the parotid gland. We report a 16‐year‐old girl with a 3‐year history of slowly progressive, painless right cheek swelling. CT and MRI showed an avidly enhancing, markedly T2‐hyperintense parotid lesion, suggesting a vascular malformation; fine‐needle aspiration yielded reactive lymphoid tissue. Contrast‐enhanced ultrasound (CEUS) demonstrated rapid, intense, homogeneous enhancement, confirming a hypervascular solid mass rather than a vascular malformation and raising suspicion for Castleman disease. Superficial parotidectomy confirmed unicentric hyaline‐vascular Castleman disease. CEUS aided differentiation of a hypervascular solid lesion from a vascular malformation and narrowed the differential.

  • Open Access

    Metastatic carcinoma mimicking hemophagocytic lymphohistiocytosis

    by Shanelle De Lancy, Kwadwo Asare Oduro


  • Open Access

    A Novel Homozygous Missense Mutation in the YARS Gene: Expanding the Phenotype of YARS Multisystem Disease

    by Rawah K H M Zeiad, Edwin C Ferren, Denise D Young, Shanelle J De Lancy, Demitrios Dedousis, Lori-Anne Schillaci, Raymond W Redline, Shahrazad T Saab, Maricruz Crespo, Tricia R Bhatti, et al.

    Aminoacyl-tRNA synthetases (ARSs) are crucial enzymes for protein translation. Mutations in genes encoding ARSs are associated with human disease. Tyrosyl-tRNA synthetase is encoded by YARS which is ubiquitously expressed and implicated in an autosomal dominant form of Charcot-Marie-Tooth and autosomal recessive YARS-related multisystem disease. We report on a former 34-week gestational age male who presented at 2 months of age with failure to thrive (FTT) and cholestatic hepatitis. He was subsequently diagnosed with hyperinsulinemic hypoglycemia with a negative congenital hyperinsulinism gene panel and F-DOPA positron-emission tomography (PET) scan that did not demonstrate a focal lesion. Autopsy findings were notable for overall normal pancreatic islet size and morphology. Trio whole exome sequencing identified a novel homozygous variant of uncertain significance in YARS (c.611A > C, p.Tyr204Cys) with each parent a carrier for the YARS variant. Euglycemia was maintained with diazoxide (max dose, 18 mg/kg/day), and enteral dextrose via gastrostomy tube (G-Tube). During his prolonged hospitalization, the patient developed progressive liver disease, exocrine pancreatic insufficiency, acute renal failure, recurrent infections, ichthyosis, hematologic concerns, hypotonia, and global developmental delay. Such multisystem features have been previously reported in association with pathogenic YARS mutations. Although hypoglycemia has been associated with pathogenic YARS mutations, this report provides more conclusive data that a YARS variant can cause hyperinsulinemic hypoglycemia. This case expands the allelic and clinical heterogeneity of YARS-related disease. In addition, YARS-related disease should be considered in the differential of hyperinsulinemic hypoglycemia associated with multisystem disease.